Lake/University Ireland Cancer Center

Cleveland, Ohio 44060

0 studies enrolling now · 9 studies all time

What they study most

Breast Cancer, Cancer, Cervical Cancer, Colorectal Cancer, Drug/Agent Toxicity by Tissue/Organ, Endometrial Cancer, Fallopian Tube Cancer, Lung Cancer, Ovarian Cancer, Peritoneal Cavity Cancer, Precancerous Condition, Radiation Toxicity

Studies at this site

• Compliance to Vaginal Dilation Therapy in Patients Who Have Undergone Radiation Therapy For Stage IB, Stage IIA, Stage IIB, Stage IIIA, or Stage IIIB Cervical Cancer or Stage IA, Stage IB, Stage IIA, or Stage IIB Endometrial Cancer — Completed
• Pemetrexed or Docetaxel With or Without Erlotinib in Stage IIIB or Stage IV Non-Small Cell Lung Cancer — Completed
• Lapatinib Resistance in Patients With Breast Cancer — Withdrawn before enrolling
• Partial Breast Radiation Therapy in Treating Women Undergoing Breast-Conserving Therapy for Early Stage Breast Cancer — Completed
• Knowledge and Perceptions About Human Papillomavirus and Cervical Cancer Risk Among Young Adults — Withdrawn before enrolling
• Sorafenib, Cisplatin, and Etoposide in Treating Patients With Extensive-Stage Small Cell Lung Cancer — Stopped early
• Differences in Timely Cancer Diagnosis in African American and Caucasian Patients With Newly Diagnosed Colorectal Cancer — Completed
• Pyridoxine in Preventing Hand-Foot Syndrome in Patients Who Are Receiving Liposomal Doxorubicin for Cancer — Completed
• Donor Mesenchymal Stem Cell Infusion in Treating Patients With Acute or Chronic Graft-Versus-Host Disease After Undergoing a Donor Stem Cell Transplant — Completed